Xylitol capsules to clear C. difficile in people with IBD
Part of Digestive system, Infections clinical trials.
This study tests whether taking xylitol (a natural sweetener) in capsule form can help clear a harmful gut bacteria called C. difficile from people with IBD. If you have mild or inactive IBD, this might be a simple way to reduce that bacteria and potentially prevent future infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You have inflammatory bowel disease (IBD) — either Crohn's disease, ulcerative colitis, or indeterminate colitis
- Your IBD should be inactive or mild (not causing severe symptoms)
- You have not had surgery to remove your colon, and you do not have a J-pouch or ostomy
- You are not taking antibiotics on a long-term basis
- You can swallow capsules and have no allergy to xylitol
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a natural sweetener called xylitol (taken by mouth) can help reduce the amount of C. difficile bacteria in your gut, which may help prevent infection. If you have mild or inactive IBD and are planning a routine appointment, you may be able to join.
This study tests two antibiotics—fidaxomicin and vancomycin—to see which is better at clearing C. difficile bacteria from the gut in people with inflammatory bowel disease. If you are having a colonoscopy, you may be able to participate.
This study tests whether taking a capsule form of fecal microbiota transplant (FMT) can help adults with their first C. difficile infection—or a first relapse—get better and reduce repeat episodes. Participants also take specific antibiotics for C. difficile as part of the study process.
This study tests whether adding a common bile acid (ursodeoxycholic acid) to your regular C. diff treatment can help stop the infection from coming back. The goal is to see if this extra medicine reduces the chance of recurrence.
This study tests whether a daily probiotic supplement (a beneficial bacteria) can improve the protective lining of the gut and reduce leakage in people with inflammatory bowel disease (IBD). It involves taking the supplement for a period of time and undergoing some measurements of gut health.
This study tests a freeze-dried fecal microbiota transplant (FMT) to see if it helps with diarrhea-predominant irritable bowel syndrome (IBS-D) or prevents repeat C. diff infections. FMT introduces healthy bacteria into your gut to restore balance.
Hear when a new Clostridioides Difficile Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.